Reboot Pain (tDCS)
This study will examine the effectiveness of tDCS (Transcranial Direct Current Stimulation) in reducing chronic pain when used with Emory Healthcare Veterans Program (EHVP)-ABHP (Accelerated Behavioral Health Program) participants as measured by the Pain, Enjoyment of Life and General Activity Scale (PEG).
| Condition(s) | Chronic Pain |
|---|---|
| Status | Recruiting |
| Phase | NA |
| Study type | Interventional |
| Summary | This study will examine the effectiveness of tDCS (Transcranial Direct Current Stimulation) in reducing chronic pain when used with Emory Healthcare Veterans Program (EHVP)-ABHP (Accelerated Behavioral Health Program) participants as measured by the Pain, Enjoyment of Life and General Activity Scale (PEG). |
| Who can participate | Inclusion Criteria: * Male or Female, 18-89 years old * Treated on site for ABHP * Willing to self-administer tDCS and complete the measures * PEG pain intensity of 4 or more for most of the day at least 3 days per week * Have an established PCP (Primary Care Provider) or pain management provider Exclusion Criteria: * Implanted pacemaker * Seizure Disorder * Pregnancy, if applicable * Any new onset of the following: * Balance Problems * Difficulty walking * Bladder incontinence * Bowel incontinence * Numbness * Tingling * Weakness * Medical contraindications * Current use of sodium channel blockers * Lidocaine (OTC/transdermal delivery is ok) * Mexiletine * Amitriptyline; other tricyclic antidepressants * Anti-epileptic medications: phenytoin, carbamazepine, lamotrigine, oxcarbazepine, ruf |
| Ages | 18 Years to 89 Years |
| Sex | All |
| Lead sponsor | Emory University |
| Locations | Atlanta, Georgia, United States |
| Start date | 2026-02-16 |
| NCT ID | NCT07411859 |
| Official listing | https://clinicaltrials.gov/study/NCT07411859 |